In a crossover trial of 16 adults with severe obstructive sleep apnoea without insomnia, 5 nights of daridorexant 50 mg vs placebo had no clinically meaningful effect on AHI (−3.7 events/h) or SpO2 (−0.12%); total sleep time rose by 32.5 min.
RCTn = 16
Fietze et al. Daridorexant in severe obstructive sleep apnea: effects on sleep-disordered breathing and sleep